KLK3 and prostate cancer: Additionally, the LacdiNAc motif (GalNAcβ1-4GlcNAc) is enriched on PSA and other glycoproteins in prostate cancer tissue, driven by β4-GALNT4 expression, and shows promise as a diagnostic and prognostic biomarker [354].